MALFORMATIONS VASCULAIRES

Ahogo CK, Ezzedine K, Prey S, Colona V, Diallo A, Boralevi F, Taïeb A, Léauté-Labrèze C. Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol. Br. J. Dermatol. 2013;169:1252 1256.

Cornelis F, Havez M, Labrèze C, Taieb A, Bui BN, Midy D, Grenier N. Percutaneous cryoablation of symptomatic localized venous malformations: preliminary short-term results. J Vasc Interv Radiol 2013;24:823 827.

Léauté-Labrèze C. [Infantile hemangioma: update and treatment]. Arch Pediatr 2013;20:517 522.

Léauté-Labrèze C, Dumas de la Roque E, Nacka F, Abouelfath A, Grenier N, Rebola M, Ezzedine K, Moore N. Double-blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants < 4 months of age. Br. J. Dermatol. 2013;169:181 183.

Moehrle M, Léauté-Labrèze C, Schmidt V, Röcken M, Poets C-F, Goelz R. Topical timolol for small hemangiomas of infancy. Pediatr Dermatol 2013;30:245 249.

Quintard B, Gana K, Constant A, Quintric C, Taïeb A, Léauté-Labrèze C. Social isolation in parents of children with hemangiomas: effects of coping styles and emotional distress. Psychol Health Med 2013;18:698 704.

Revencu N, Boon LM, Mendola A, Cordisco MR, Dubois J, Clapuyt P, Hammer F, Amor DJ, Irvine AD, Baselga E, Dompmartin A, Syed S, Martin-Santiago A, Ades L, Collins F, Smith J, Sandaradura S, Barrio VR, Burrows PE, Blei F, Cozzolino M, Brunetti-Pierri N, Vicente A, Abramowicz M, Désir J, Vilain C, Chung WK, Wilson A, Gardiner CA, Dwight Y, Lord DJE, Fishman L, Cytrynbaum C, Chamlin S, Ghali F, Gilaberte Y, Joss S, Boente MDC, Léauté-Labrèze C, Delrue M-A, Bayliss S, Martorell L, González-Enseñat M-A, Mazereeuw-Hautier J, O’Donnell B, Bessis D, Pyeritz RE, Salhi A, Tan OT, Wargon O, Mulliken JB, Vikkula M. RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum. Mutat. 2013;34:1632 1641.

TOXIDERMIES

Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M, Grange A, Amarger S, Girardin P, Guinnepain M-T, Truchetet F, Lasek A, Waton J, Toxidermies group of the French Society of Dermatology. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br. J. Dermatol. 2013;168:555 562.

MALADIES INFECTIEUSES

Beau C, Vlassova N, Sarlangue J, Brissaud O, Léauté-Labrèze C, Boralevi F. Diagnostic value of polymerase chain reaction analysis of skin biopsies in purpura fulminans. Pediatr Dermatol 2013;30:e276 277.

VITILIGO

Benzekri L, Ezzedine K, Gauthier Y. Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy. Br. J. Dermatol. 2013;168:1143 1146.

Diallo A, Boniface K, Jouary T, Seneschal J, Morice-Picard F, Prey S, Cario-André M, Mazereeuw-Hautier J, Taieb A, Ezzedine K. Development and validation of the K-VSCOR for scoring Koebner’s phenomenon in vitiligo/non-segmental vitiligo. Pigment Cell Melanoma Res 2013;26:402 407.

Ezzedine K, Le Thuaut A, Jouary T, Ballanger F, Taieb A, Bastuji-Garin S. Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma Res 2014;27:134 139

Gey A, Diallo A, Seneschal J, Léauté-Labrèze C, Boralevi F, Jouary T, Taieb A, Ezzedine K. Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms. Br. J. Dermatol. 2013;168:756 761.

Taieb A, Alomar A, Böhm M, Dell’anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, Leone G, Moretti S, Nieuweboer-Krobotova L, Olsson MJ, Parsad D, Passeron T, Tanew A, van der Veen W, van Geel N, Whitton M, Wolkerstorfer A, Picardo M, Vitiligo European Task Force (VETF), European Academy of Dermatology and Venereology (EADV), Union Européenne des Médecins Spécialistes (UEMS). Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br. J. Dermatol. 2013;168:5 19.

Taïeb A, Ezzedine K. Vitiligo: the white armour? Pigment Cell Melanoma Res 2013;

Taïeb A, Seneschal J. Targeting iHSP 70 in vitiligo: a critical step for cure? Exp. Dermatol. 2013;22:570 571.

PIGMENTATION

Ezzedine K, Mauger E, Latreille J, Jdid R, Malvy D, Gruber F, Galan P, Hercberg S, Tschachler E, Guinot C. Freckles and solar lentigines have different risk factors in Caucasian women. J Eur Acad Dermatol Venereol 2013;27:e345 356.

Jdid R, Ezzedine K, Latreille J, Galan P, Hercberg S, Malvy D, Tschachler E, Guinot C. MC1R major variants are a risk factor of sleep lines in Caucasian women. J Eur Acad Dermatol Venereol 2013

CANCEROLOGIE

Bertolotti A, Conte H, François L, Dutriaux C, Ezzedine K, Mélard P, Vergier B, Taieb A, Jouary T. Merkel cell carcinoma: complete clinical remission associated with disease progression. JAMA Dermatol 2013;149:501 502.

Bertolotti A, Conte H, Amazan E, Dutriaux C, Ezzedine K, Parrens M, Vergier B, Taieb A, Jouary T. Metastatic melanoma with leukaemia-like evolution. Acta Derm. Venereol. 2013;93:729 730.

Boursault L, Haddad V, Vergier B, Cappellen D, Verdon S, Bellocq J-P, Jouary T, Merlio J-P. Tumor homogeneity between primary and metastatic sites for BRAF status in metastatic melanoma determined by immunohistochemical and molecular testing. PLoS ONE 2013;8:e70826.

Grob JJ, Jouary T, Dréno B, Asselineau J, Gutzmer R, Hauschild A, Leccia MT, Landthaler M, Garbe C, Sassolas B, Herbst RA, Guillot B, Chene G, Pehamberger H. Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study. Eur. J. Cancer 2013;49:166 174.

Puntervoll HE, Yang XR, Vetti HH, Bachmann IM, Avril MF, Benfodda M, Catricalà C, Dalle S, Duval-Modeste AB, Ghiorzo P, Grammatico P, Harland M, Hayward NK, Hu H-H, Jouary T, Martin-Denavit T, Ozola A, Palmer JM, Pastorino L, Pjanova D, Soufir N, Steine SJ, Stratigos AJ, Thomas L, Tinat J, Tsao H, Veinalde R, Tucker MA, Bressac-de Paillerets B, Newton-Bishop JA, Goldstein AM, Akslen LA, Molven A. Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. J. Med. Genet. 2013;50:264 270.

DERMATITE ATOPIQUE

Darsow U, Wollenberg A, Simon D, Taïeb A, Werfel T, Oranje A, Gelmetti C, Svensson A, Deleuran M, Calza A-M, Giusti F, Lübbe J, Seidenari S, Ring J, European Task Force on Atopic Dermatitis / EADV Eczema Task Force. Difficult to control atopic dermatitis. World Allergy Organ J 2013;6:6.

Boralevi F, Saint Aroman M, Delarue A, Raudsepp H, Kaszuba A, Bylaite M, Tiplica GS. Long-term emollient therapy improves xerosis in children with atopic dermatitis. J Eur Acad Dermatol Venereol 2013

GENODERMATOSES

Dreyfus I, Bourrat E, Maruani A, Bessis D, Chiavérini C, Vabres P, Ezzedine K, Mazereeuw-Hautier J. Factors Associated with Impaired Quality of Life in Adult Patients Suffering from Ichthyosis. Acta Derm. Venereol. 2013

Dreyfus I, Taïeb C, Barbarot S, Maza A, Galera I, Bourrat E, Chiaverini C, Ezzedine K, Le Rhun A, Mazereeuw-Hautier J. IQoL-32: a new ichthyosis-specific measure of quality of life. J. Am. Acad. Dermatol. 2013;69:82 87

Eytan O, Qiaoli L, Nousbeck J, van Steensel MAM, Burger B, Hohl D, Taieb A, Prey S, Bachmann D, Avitan-Hersh E, Jin Chung H, Shemer A, Trau H, Bergman R, Fuchs-Telem D, Warshauer E, Israeli S, Itin PH, Sarig O, Uitto J, Sprecher E. Increased epidermal expression and absence of mutations in CARD14 in a series of sporadic PRP patients. Br. J. Dermatol. 2013

Eytan O, Morice-Picard F, Sarig O, Ezzedine K, Isakov O, Li Q, Ishida-Yamamoto A, Shomron N, Goldsmith T, Fuchs-Telem D, Adir N, Uitto J, Orlow SJ, Taieb A, Sprecher E. Cole Disease Results from Mutations in ENPP1. Am. J. Hum. Genet. 2013;93:752 757.

Hadj-Rabia S, Oriot D, Soufir N, Dufresne H, Bourrat E, Mallet S, Poulhalon N, Ezzedine E, Grandchamp B, Taïeb A, Catteau B, Sarasin A, Bodemer C. Unexpected extradermatological findings in 31 patients with xeroderma pigmentosum type C. Br. J. Dermatol. 2013;168:1109 1113.

Morice-Picard F, Ezzedine K, Delrue M-A, Arveiler B, Fergelot P, Taïeb A, Lacombe D, Boralevi F. Cutaneous manifestations in Costello and cardiofaciocutaneous syndrome: report of 18 cases and literature review. Pediatr Dermatol 2013;30:665 673.

SCLERODERMIE

Guillevin L, Hunsche E, Denton CP, Krieg T, Schwierin B, Rosenberg D, Matucci-Cerinic M, DUO Registry Group. Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. Clin. Exp. Rheumatol. 2013;31:71 80.

ROSACEE

Prey S, Ezzedine K, Mazereeuw-Hautier J, Eschard C, Barbarot S, Boralevi F, Taïeb A, Léaute-Labrèze C, Groupe de Recherche Clinique en Dermatologie Pédiatrique. IFAG and childhood rosacea: a possible link? Pediatr Dermatol 2013;30:429 432.

RECHERCHE U1035

Latreille J, Kesse-Guyot E, Malvy D, Andreeva V, Galan P, Tschachler E, Hercberg S, Guinot C, Ezzedine K. Association between dietary intake of n-3 polyunsaturated fatty acids and severity of skin photoaging in a middle-aged Caucasian population. J. Dermatol. Sci. 2013;72:233 239.

Le Clerc S, Taing L, Ezzedine K, Latreille J, Delaneau O, Labib T, Coulonges C, Bernard A, Melak S, Carpentier W, Malvy D, Jdid R, Galan P, Hercberg S, Morizot F, Guinot C, Tschachler E, Zagury JF. A genome-wide association study in Caucasian women points out a putative role of the STXBP5L gene in facial photoaging. J. Invest. Dermatol. 2013;133:929 935.

Simon D, Daubos A, Pain C, Fitoussi R, Vié K, Taieb A, de Benetti L, Cario-André M. Exposure to acute electromagnetic radiation of mobile phone exposure range alters transiently skin homeostasis of a model of pigmented reconstructed epidermis. Int J Cosmet Sci 2013;35:27 34.

Rouault-Pierre K, Lopez-Onieva L, Foster K, Anjos-Afonso F, Lamrissi-Garcia I, Serrano-Sanchez M, Mitter R, Ivanovic Z, de Verneuil H, Gribben J, Taussig D, Rezvani HR, Mazurier F, Bonnet D. HIF-2α protects human hematopoietic stem/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress. Cell Stem Cell. 2013 Nov 7;13(5):549-63.

Melser S, Chatelain EH, Lavie J, Mahfouf W, Jose C, Obre E, Goorden S, Priault M, Elgersma Y, Rezvani HR, Rossignol R, Bénard G. Rheb regulates mitophagy induced by mitochondrial energetic status. Cell Metab. 2013 May 7;17(5):719-30.

ARCHIVES

Publications 2012

Publications 2011